Search - tctmd.com

Displaying 361 - 380 of 652

Sort: Relevancy | Date

News Daily News

Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited

Michael O'Riordan

August 03, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2021

Shelley Wood

August 02, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Conference News HRS 2021

STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation

Todd Neale

July 29, 2021

News Daily News

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Yael L. Maxwell

July 09, 2021

News Daily News

Making the Case for Sex-Specific CVD Guidelines

L.A. McKeown

July 08, 2021

News Daily News

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Todd Neale

July 06, 2021

News Daily News

Big Downturn in CVD Procedures Seen During COVID-19’s First Wave

Michael O'Riordan

July 01, 2021

News Daily News

Less Cancer Among HF Patients Taking Statins, Registry Shows

Michael O'Riordan

June 23, 2021

News Daily News

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

L.A. McKeown

June 23, 2021

News Daily News

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

Michael O'Riordan

June 18, 2021

News Daily News

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

L.A. McKeown

June 18, 2021

News Daily News

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Michael O'Riordan

June 16, 2021

News Daily News

Closing the Gender Gap in Cardiology Clinical Trial Leadership: A Road Map

Shelley Wood

June 11, 2021

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Daily News

Final SPRINT Results Endorse Intensive BP Control

Todd Neale

May 25, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May Week 3

Shelley Wood

May 17, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

Advertisement

Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited

TCTMD’s Top 10 Most Popular Stories for July 2021

July/August 2021 News Roundup

STROKE-VT: DOACs Cut Cerebrovascular Events After LV Arrhythmia Ablation

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Making the Case for Sex-Specific CVD Guidelines

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Big Downturn in CVD Procedures Seen During COVID-19’s First Wave

Less Cancer Among HF Patients Taking Statins, Registry Shows

Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA

LDL Cholesterol-Lowering Meds Rarely Intensified: GOULD

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

Stopping Statins Ups CVD and Mortality Risks in Pill-Burdened Seniors

Closing the Gender Gap in Cardiology Clinical Trial Leadership: A Road Map

June 2021 News Roundup

Final SPRINT Results Endorse Intensive BP Control

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

COVID-19: TCTMD’s Daily Dispatch for May Week 3

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content